CD146 as a promising therapeutic target for retinal and choroidal neovascularization diseases ( vol 65 , pg 1157 , 2022)

被引：0

作者：

Xue, Bai ^{[1
]}

Wang, Ping ^{[2
]}

Yu, Wenzhen ^{[3
]}

Feng, Jing ^{[2
]}

Li, Jie ^{[4
]}

Zhao, Rulian ^{[1
]}

Yan, Zhenglin ^{[1
,5
]}

Yan, Xiyun ^{[2
,6
,7
]}

Duan, Hongxia ^{[2
]}

机构：

[1] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Sch Med, Sichuan Prov Key Lab Human Dis Gene Study, Chengdu 610072, Peoples R China

[2] Chinese Acad Sci, Inst Biophys, Key Lab Prot & Peptide Pharmaceut, Beijing 100101, Peoples R China

[3] Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100044, Peoples R China

[4] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Dept Ophthalmol, Chengdu 610072, Peoples R China

[5] Chinese Acad Med Sci 2019RU026, Res Unit Blindness Prevent, Sichuan Acad Med Sci & Sichuan Prov Peoples Hosp, Chengdu 610072, Peoples R China

[6] Zhengzhou Univ, Nanozyme Med Ctr, Sch Basic Med Sci, Zhengzhou 450001, Peoples R China

[7] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China

来源：

关键词：

D O I：

10.1007/s11427-023-2427-x

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：434 / 434

页数：1